Results 261 to 270 of about 74,181 (306)
Some of the next articles are maybe not open access.
Clinical Anatomy, 2002
AbstractA meticulous examination was performed on 56 vertebral columns from cadavers between 64 and 89 years of age. Identification of all contents within the dural sac was completed; however, the main focus was the cauda equina and lumbar region.
David E, Kershner, Robert T, Binhammer
openaire +2 more sources
AbstractA meticulous examination was performed on 56 vertebral columns from cadavers between 64 and 89 years of age. Identification of all contents within the dural sac was completed; however, the main focus was the cauda equina and lumbar region.
David E, Kershner, Robert T, Binhammer
openaire +2 more sources
Encapsulation of an intrathecal catheter
Pain, 2003A 47-year-old patient with cancer pain underwent implantation of an intrathecal drug delivery device. When the patient suffered from an infection with fever, pain on injection into the catheter and an elevated number of granulocytes in the cerebrospinal fluid 7 weeks later, radiologic examination showed an encapsulation of the catheter tip ...
Jan, Gaertner +3 more
openaire +2 more sources
Spasticity and Intrathecal Baclofen
Seminars in Neurology, 2014Severe spastic tone and/or spastic hypertonia can be the most disabling consequences of a neurologic insult, resulting from an excess of muscle tone. Baclofen, a GABA-B agonist, is one of the most widely used drugs in treating abnormal or disabling spastic tone.
Erin, Furr-Stimming +2 more
openaire +2 more sources
Intrathecal Delivery of Analgesics
2014Targeted intrathecal (IT) drug delivery systems (IDDS) are an option in algorithms for the treatment of patients with moderate to severe chronic refractory pain when more conservative options fail. This therapy is well established and supported by several publications.
Jose, De Andres +2 more
openaire +2 more sources
2019
Targeted intrathecal (IT) drug delivery systems (IDDS) are well established as an effective treatment of patients with chronic nonmalignant or malignant pain, and as a tool for management of patients with severe spasticity. The risk to benefit ratio of IDD makes it a relatively safe therapy for both cancer- and noncancer-related pain, but it is not ...
José, De Andrés +4 more
openaire +2 more sources
Targeted intrathecal (IT) drug delivery systems (IDDS) are well established as an effective treatment of patients with chronic nonmalignant or malignant pain, and as a tool for management of patients with severe spasticity. The risk to benefit ratio of IDD makes it a relatively safe therapy for both cancer- and noncancer-related pain, but it is not ...
José, De Andrés +4 more
openaire +2 more sources